Live Markets: US stocks gain early with boost from financials, tech
LIVE MARKETS-US stocks gain early with boost from financials, tech Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
US STOCKS GAIN EARLY WITH BOOST FROM FINANCIALS, TECH
Major U.S. stock indexes are higher in early trading, helped by gains in chip stocks and other technology shares.
Investors are keeping a close eye on news on the U.S.-Iran conflict, with Iran's armed forces launching attacks on U.S. military infrastructure in Gulf states on Thursday following U.S. strikes on Iran's southern coastal and eastern provinces.
The latest developments put more strain on a three-week-old ceasefire agreement.
The attacks came on the day that Iran buries its slain Supreme Leader Ayatollah Ali Khamenei at the shrine of Mashhad, in the culmination of a week of mass funeral processions and rallies. Khamenei was killed in a U.S. airstrike on the first day of the war on February 28.
The S&P 500 technology sector .SPLRCT up about 1% and is leading sector gains along with financials .SPSY, which are also up around 1%. An index of semiconductors .SOX, which has seen much volatility recently, is up more than 4%.
Here is the early market snapshot:
(Caroline Valetkevitch)
*****
EARLIER ON LIVE MARKETS:
GEOPOLITICAL RISK LIFTS OIL, ENERGY STOCKS JOIN THE REBOUND CLICK HERE
TALKS, TARIFFS, AND STILL NO RESULTS? CLICK HERE
CITI SCRAPS LONG EUROPEAN EQUITIES RECOMMENDATION CLICK HERE
EUROPEAN SOFTWARE SEARCHES FOR A CATALYST AS EARNINGS NEAR CLICK HERE
STOXX BOUNCES BACK, ASTRAZENECA DRAGS CLICK HERE
BEFORE THE BELL: TECH LEADS EUROPE HIGHER AS OIL EASES CLICK HERE
CHIP EUPHORIA VIES WITH WAR WEARINESS CLICK HERE
( )
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains